ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FAB Fusion Antibodies Plc

3.75
-0.05 (-1.32%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.32% 3.75 3.70 3.80 3.80 3.75 3.80 187,413 08:00:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0437 -0.86 2.23M

Fusion Antibodies PLC Investor presentation

23/04/2018 10:09am

RNS Non-Regulatory


TIDMFAB

Fusion Antibodies PLC

23 April 2018

23 April 2018

Fusion Antibodies plc

("Fusion" or the "Company")

Investor presentation

Fusion Antibodies (AIM: FAB), a contract research organization providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications, announces that it will hold a presentation for investors on Wednesday, 2 May 2018.

The briefing by Paul Kerr, CEO of Fusion will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, EC2N 1DX from 4.30pm for a 4.45pm start and will be followed by drinks and networking. If you would like to register to attend, please contact Walbrook PR on 020 7933 8780 or email fusion@walbrookpr.com.

Enquiries:

 
 Fusion Antibodies plc                                  www.fusionantibodies.com 
 Dr Paul Kerr, Chief Executive Officer                           Via Walbrook PR 
 James Fair, Chief Financial Officer 
 
 Walbrook PR                   Tel: +44 (0)20 7933 8780 or fusion@walbrookpr.com 
 Paul McManus                                           Mob: +44 (0)7980 541 893 
 Anna Dunphy                                            Mob: +44 (0)7876 741 001 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAPGUMUCUPRUBW

(END) Dow Jones Newswires

April 23, 2018 05:09 ET (09:09 GMT)

1 Year Fusion Antibodies Chart

1 Year Fusion Antibodies Chart

1 Month Fusion Antibodies Chart

1 Month Fusion Antibodies Chart

Your Recent History

Delayed Upgrade Clock